Medical Xpress December 1, 2024
Tad Carper had no idea the technology to detect more than 50 cancers with one test existed. He does now, and the Dallas Cowboys senior vice president of communication wants to help spread the word.
Carper recently underwent surgery for Stage 2 throat cancer. He exhibited no symptoms. The Galleri blood test, developed by GRAIL, allowed him to attack the cancer sooner than he would have been able to otherwise.
The story of Carper and others helps put a face on its impact and increases awareness of this relatively new technology.
“There is nothing that is more motivating and inspiring than hearing these stories,” said Dr. Josh Ofman, president of GRAIL, a California-based biotech company that specializes in early cancer...
Today's Sponsors
Today's Sponsor